---
layout: splash
title: 에이비엘바이오 (298380)
excerpt: 에이비엘바이오의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
- 고PER
- 고PBR
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 19,900 | <span style="color: cornflowerblue">-2.5<small>%</small></span> | Q:제약 | 297.0 | 13.7 | - |

<!-- more -->

<br>
> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 항체의약품 연구개발 |
| <span style="white-space:nowrap;">**상장일**</span> | 2018년 12월 19일 |
| <span style="white-space:nowrap;">**결산월**</span> | 12월 |
| <span style="white-space:nowrap;">**대표자**</span> | 이상훈 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.ablbio.com](http://www.ablbio.com){:target="_blank"} |

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;07 | | [매출액또는손익구조30%(대규모법인은15%)이상변동              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240207901225){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![298380](/stock/images/298380.png){: .align-center}

<br>
> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 19,900 | <span style="color: cornflowerblue">-2.5<small>%</small></span> | <span style="color: cornflowerblue">-8.7<small>%</small></span> | <span style="color: cornflowerblue">-17.1<small>%</small></span> | <span style="color: tomato">7.3<small>%</small></span> | <span style="color: cornflowerblue">-1.0<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-8.3<small>%</small></span> | 45.2<small>%</small> | -0.18 | -39.3<small>%</small> | -17.6<small>%</small> | 0.2 |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 297.0 | 13.7 | - | 고PER, 고PBR |

<br>
> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/298380/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=298380){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A298380&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=298380){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/298380){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/298380/financial-summary){:target="_blank"} |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![298380](/stock/images/298380_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -8.3<small>%</small> | 45.2<small>%</small> | -0.18 | -39.3<small>%</small> | -17.6<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -2.3<small>%</small> | 44.7<small>%</small> | -0.05 | -35.0<small>%</small> | -15.5<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -7.6<small>%</small> | 34.9<small>%</small> | -0.22 | -44.1<small>%</small> | -21.3<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 8.4<small>%</small> | 32.8<small>%</small> | 0.26 | -24.8<small>%</small> | -10.3<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -32.5<small>%</small> | 29.4<small>%</small> | -1.11 | -40.7<small>%</small> | -30.2<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -14.9<small>%</small> | 31.6<small>%</small> | -0.47 | -25.1<small>%</small> | -13.5<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -29.3<small>%</small> | 27.0<small>%</small> | -1.09 | -31.9<small>%</small> | -24.1<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -18.3<small>%</small> | 24.3<small>%</small> | -0.75 | -22.7<small>%</small> | -13.9<small>%</small> |
| MACD[^fn_tech_metric_macd] | -8.9<small>%</small> | 32.0<small>%</small> | -0.28 | -27.2<small>%</small> | -17.9<small>%</small> |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![298380](/stock/images/298380_corr.png){: .align-center}

|       | [HLB생명과학](/067630/) | [지씨셀](/144510/) | [녹십자홀딩스](/005250/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [넷마블](/251270/) | [HLB](/028300/) | [커넥트웨이브](/119860/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![298380](/stock/images/298380_2x.png){: .align-center}

<br>
> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info} [고PER 목록](/fn/fn_high_per/){: .btn .btn--info} [고PBR 목록](/fn/fn_high_pbr/){: .btn .btn--info}

{% include commons/footnotes.md %}